Sanofi Acquires Dynavax Technologies for $2.2 Billion
Sanofi is rounding out 2025 with a multi-billion-dollar transaction. On December 24, the company announced that it entered into an agreement to acquire Dynavax Technologies Corporation, based in Emeryville, California. Under the terms of the agreement, Sanofi will commence a cash tender offer to acquire all outstanding shares of Dynavax for $15.50 per share in cash, reflecting a total equity value of approximately $2.2 billion. Dynavax Technologies is a publicly traded vaccines company with a marketed adult hepatitis B vaccine (HEPLISAV-B®) and a differentiated shingles vaccine candidate (Z-1018). According to its most recent annual SEC filing, Dynavax reported approximately $277.2 million... Read More »
Key Insights from C3 Think Tank CEO on the Changing Dental M&A Landscape
Dentistry is entering a period of rapid change as private equity activity, new insurance rules and faster cycles of clinical innovation start to collide with a sector that has historically maintained a high degree of clinical and operational autonomy. Few people track that shift as closely as Prof. Dr. Claudia C. Cotca, whose dual role as a practicing dental surgeon and founder of C3 Think Tank gives her a view into both daily patient care and the policy conversations shaping the market. From her position, she argues that dentistry’s greatest strength (its clinician-led and open-market structure) is also what makes the current M&A wave more consequential than many investors recognize.... Read More »Deal of the Week: MedStar Health Acquires Hope for Henry
In LevinPro HC’s Deal of the Week, MedStar Health, one of the largest health systems in the mid-Atlantic, acquired a national non-profit organization focused on patient experience and engagement. The non-profit, Hope for Henry Foundation, uses behavioral economics to motivate step-by-step adherence, reduce anxiety, and improve clinical and operational outcomes for pediatric patients. According to the organization’s website, it has partnered with more than 40 hospitals and has assisted more than 150,000 pediatric patients. The deal is a full-circle moment, since Hope for Henry was founded at MedStar Georgetown University Hospital in 2003. MedStar Health is the largest healthcare... Read More »
Allied OMS Acquires Oral & Maxillofacial Surgery of Central New Jersey
Allied OMS announced on December 19 that it acquired its first practice in New Jersey with the acquisition of Oral & Maxillofacial Surgery of Central New Jersey. Founded in 1972, Oral & Maxillofacial Surgery of Central New Jersey is based in two New Jersey locations: Princeton Junction and Mercerville. According to its website, there are two doctors on staff: Dr. Sean E. Bradley and Dr. Jonathon S. Sasportas. Allied OMS is a doctor-owned, doctor-led management services organization in the oral and maxillofacial surgery space. Headquartered in Southlake, Texas, Allied OMS has 41 surgeons serving patients out of 36 locations across California, Colorado, New York, Oregon,... Read More »
Samsung Biologics America Acquires Human Genome Sciences
On December 21, Samsung Biologics announced that its portfolio company, Samsung Biologics America (SBA), will acquire a 100% stake in Human Genome Sciences from GSK. Under the terms of the agreement, with closing anticipated toward the end of Q1 of 2026, the purchase price is $280 million. Human Genome Sciences operates as a biopharmaceutical company in the United States. Its principal products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. Samsung Biologics is a leading contract development and manufacturing organization, offering end-to-end integrated services that range from late discovery to commercial manufacturing. SBA is Samsung... Read More »
Innova Therapeutics Advances Novel Cancer Treatment With Enci Therapeutics Deal
Innova Therapeutics has completed its purchase of South Carolina-based biotechnology company Enci Therapeutics. The acquisition includes Enci Therapeutics’ main cancer therapeutic program, IVT-8086. IVT-8086 is a first-in-class, humanized monoclonal antibody (mAb) developed as a cancer therapeutic that targets and antagonizes the Secreted Frizzled-Related Protein 2 (SFRP2) pathway. SFRP2 is a protein expressed at high levels in many solid and hematological malignancies, and its expression is correlated with patient outcomes, including overall survival, making it an important therapeutic target. As an SFRP2 antagonist, IVT-8086 selectively blocks the non-canonical Wnt/Ca2+ signaling... Read More »
Brown’s Medical Imaging and Prestige Medical Imaging Merge
Brown’s Medical Imaging announced that it has completed its merger with Prestige Medical Imaging (PMI), unifying the organization under the Brown’s Medical Imaging brand. PMI is the largest independent radiology service and solutions provider in the Eastern United States. Its customer base includes private practice practitioners, professional sports teams and hospital healthcare networks. The company sells, services and supports a vast array of modalities across numerous manufacturers. Founded in 1995 and headquartered in Omaha, Nebraska, Brown’s Medical Imaging is a medical imaging solutions company providing equipment, service, maintenance, services and support to hospitals,... Read More »Hospital Mega-Deals Fall to Just 15% in 2025
Our latest Stat of the Month highlights a significant shift in Hospital M&A, and what it signals for investors and strategics heading into 2026. According to transaction activity we captured in our LevinPro HC database, only 15% of all Hospital transactions in the first nine months of 2025 had target revenue exceeding $500 million. That’s compared to 31% in the same period in 2024, a significant swing in the type of Hospital deals we’re seeing in the market. In 2024, health systems were focused on generating scale, exemplified by mergers from organizations like Lehigh Valley Health Network and Jefferson Health, which created a network of more than 30 hospitals. This year, however,... Read More »
Transwestern Real Estate Services Advises On Granbury, Texas Sale
Transwestern Real Estate Services announced that it facilitated the sale of a medical outpatient building (MOB) in Granbury, Texas. Neither the buyer nor the seller were disclosed. The MOB, known as Fall Creek Medical Plaza, comprises 16,464 square feet and is 100% occupied. The financial terms of the transaction were not disclosed. This also marks the second transaction that Transwestern Real Estate Services has advised on in 2025; in June, the company advised on a three-location MOB portfolio in Temple and Belton, Texas. The portfolio comprises 31,545 square feet. According to data captured in the LevinPro HC database, this transaction marks the 201st MOB deal of... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
